Research graph
References from Association between fibroblast growth factor 23 and coronary artery calcification in patients with chronic kidney disease: a meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic kidney disease
10.1093/med/9780199568741.003.0163 · 2026 · External reference
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
10.1016/s0140-6736(20)30045-3 · 2020 · External reference
Increased cardiovascular risk in patients with chronic kidney disease
10.1161/circresaha.123.321752 · 2024 · External reference
Cardiovascular disease in chronic kidney disease
10.1093/eurheartj/ehaf167 · 2025 · External reference
Progression of coronary artery calcification and risk of clinical events in CKD: The Chronic Renal Insufficiency Cohort Study
10.1053/j.ajkd.2024.06.018 · 2025 · External reference
Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)
10.1016/j.atherosclerosis.2020.07.026 · 2020 · External reference
Chronic kidney disease and coronary artery disease: JACC state-of-the-art review
10.1016/j.jacc.2019.08.1017 · 2019 · External reference
Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease
10.1001/jamacardio.2017.0363 · 2017 · External reference
Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis
10.1080/0886022x.2019.1595646 · 2019 · External reference
Understanding vascular calcification in chronic kidney disease: Pathogenesis and therapeutic implications
10.3390/ijms252313096 · 2024 · External reference
Coronary artery-specific changes in patients with chronic kidney disease
10.3390/cells15090765 · 2026 · External reference
The role of fibroblast growth factor 23 in inflammation and anemia
10.3390/ijms20174195 · 2019 · External reference
FGF23: A player not only in bone diseases
10.1016/j.jbspin.2025.105988 · 2026 · External reference
FGF23 and phosphate-cardiovascular toxins in CKD
10.3390/toxins11110647 · 2019 · External reference
Contribution of phosphate and FGF23 to CKD progression
10.1097/mnh.0000000000000793 · 2022 · External reference
Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies
10.1038/s41598-024-56377-8 · 2024 · External reference
Effects of fibroblast growth factor 23 (FGF23) on the cardiovascular system: A review of literature
10.7759/cureus.97147 · 2025 · External reference
Vascular calcification in chronic kidney disease and hemodialysis: Pathophysiological mechanisms and emerging biomarkers
10.3390/medicina61122169 · 2025 · External reference
Fibroblast growth factor 23 at the crossroads of mineral metabolism and bone disease
10.1097/mnh.0000000000001193 · 2026 · External reference
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease
10.1161/circulationaha.108.844506 · 2009 · External reference
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients
10.1371/journal.pone.0036175 · 2012 · External reference
Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients
10.1371/journal.pone.0093360 · 2014 · External reference
Association of serum FGF23 with the cardiovascular calcification and left ventricular hypertrophy in maintenance hemodialysis patients
2015 · External reference
Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D
10.1097/cm9.0000000000001148 · 2015 · External reference
FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients
10.1007/s11255-016-1231-1 · 2016 · External reference
Analysis of influencing factors of coronary artery calcification in patients with chronic kidney disease
2018 · External reference
High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study
10.1093/ndt/gfy110 · 2019 · External reference
Study on the related factors of coronary calcification in patients with chronic kidney disease
2019 · External reference
Calcification biomarkers, subclinical vascular disease, and mortality among multiethnic dialysis patients
10.1016/j.ekir.2020.07.033 · 2020 · External reference
Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients
10.1080/0886022x.2023.2220412 · 2023 · External reference
Association of serum Klotho and fibroblast growth factor-23 levels with vascular calcification severity in patients with chronic kidney disease: an observational cohort study
10.1007/s11255-025-04475-5 · 2025 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.31222/osf.io/v7gm2 · 2021 · External reference
Unresolved reference
2021 · External reference
Quantification of coronary artery calcium using ultrafast computed tomography
10.1016/0735-1097(90)90282-t · 1990 · External reference
Unresolved reference
External reference
The relation between eHealth literacy and health-related behaviors: Systematic review and meta-analysis
10.2196/40778 · 2023 · External reference
Quantifying heterogeneity in a meta-analysis
10.1191/026921699666884611 · 2002 · External reference
Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals
10.1186/s12874-020-00966-4 · 2020 · External reference
Bias in meta-analysis detected by a simple, graphical test
10.1136/bmj.315.7109.629 · 1997 · External reference
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
10.1016/j.bone.2016.11.012 · 2017 · External reference
Heterogeneous regulation of fibroblast growth factor 23 in acute kidney injury, chronic kidney disease, and polycystic kidney disease: mechanisms, diagnostic utility, and clinical implications
10.3389/fmolb.2026.1764206 · 2026 · External reference
Arterial stiffness: A focus on vascular calcification and its link to bone mineralization
10.1161/atvbaha.120.313131 · 2020 · External reference
Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway
10.1002/kjm2.12072 · 2019 · External reference
High phosphate-induced JAK-STAT signalling sustains vascular smooth muscle cell inflammation and limits calcification
10.3390/biom14010029 · 2023 · External reference
Fibroblast growth factor-23 remodels vascular extracellular matrix via glycosaminoglycan induction: implications for calcification in chronic kidney disease
10.1080/0886022x.2025.2567528 · 2025 · External reference
Phosphate in cardiovascular disease: From new insights into molecular mechanisms to clinical implications
10.1161/atvbaha.123.319198 · 2024 · External reference
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23
10.1146/annurev.med.051308.111339 · 2010 · External reference
FGF-23 and the progression of coronary arterial calcification in patients new to dialysis
10.2215/cjn.02160212 · 2012 · External reference
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
10.1186/1471-2369-14-241 · 2013 · External reference
Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study
10.1016/j.atherosclerosis.2018.02.009 · 2018 · External reference
Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis
10.1001/jamanetworkopen.2023.10909 · 2023 · External reference
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
10.1097/mnh.0b013e328351a391 · 2012 · External reference